Cidara Therapeutics Inc (CDTX) earnings · rev $1.3M
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
This CDTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
When the next CDTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 94.5% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CDTX research stays on the stock page; the tape stays on the quote page.
Not investment advice.